A one-year non-exclusive licence to 23andMe's genetic and health survey database, including new data and some added analyses, to GSK (after the exclusive period ended)
a $20 million upfront payment for a one year, non-exclusive data license for a one-year licence
Dated 30 Oct 2023Source checked 19 Oct 2026Basis: stated
In the source's own words
“Under an amendment to their Collaboration Agreement, 23andMe will receive a $20 million upfront payment for a one year, non-exclusive data license.”
Where it was read
What it is about
Figures it counts in
- $20M to $50M per contract yearCompany records, sales that happened, per contract year
- 2.5 to 5 timesWhat an exclusive licence fetches, against a non-exclusive one
Cited in these 3 guides